Showing 5511-5520 of 5909 results for "".
- Zeiss Ranked Best Company in Germany’s Public Value Atlashttps://modernod.com/news/zeiss-ranked-best-company-in-germanys-public-value-atlas/2476600/Zeiss is Germany’s highest-ranked company in the 2019 Public Value Atlas (Gemeinwohlatlas 2019). The announcement was made in Berlin by the authors of the study, the Center for Leadership and Values in Society at the University of St. Gallen (CLVS-HSG) in cooperation with the Dr. Arend Oetk
- Ocular Therapeutix OTX-TP Intracanalicular Insert Fails to Meet Phase 3 Endpointhttps://modernod.com/news/ocular-therapeutix-otx-tp-intracanalicular-insert-fails-to-meet-phase-3-endpoint/2476598/Ocular Therapeutix’s intracanalicular insert failed to meet its primary endpoint of statistically significant superiority in mean reduction of IOP compared with placebo at all nine time points, according to a company news release. OTX-TP is an intracanalicular insert that delivers a
- Surgical Specialties Launches Caliber Ophthalmics Division to Focus on Global Growth of Ophthalmic Surgical Procedureshttps://modernod.com/news/surgical-specialties-launches-caliber-ophthalmics-division-to-focus-on-global-growth-of-ophthalmic-surgical-procedures/2476597/Surgical Specialties Corporation (SSC) announced the launch of Caliber Ophthalmics, a new business division that combines SSC’s Sharpoint brand with its two recent ophthalmic acquisitions, Unique Technologies and VPM Surgical. To lead the Caliber Ophthalmics division, SSC has named <
- Patients Equally Pleased With Different Keratoplasty Approacheshttps://modernod.com/news/patients-equally-pleased-with-different-keratoplasty-approaches/2476586/Although the Descemet Endothelial Thickness Comparison Trial (DETECT) showed better visual acuity with a newer, more demanding corneal transplantation method, this did not translate into greater patient satisfaction, according to a secondary analysis of outcome data, as
- Allegro Announces Positive Results of Ex-US Proof-of-Concept Trial With ALG-1007 for Dry Eye Diseasehttps://modernod.com/news/allegro-ophthalmics-announces-positive-results-of-ex-us-proof-of-concept-trial-with-integrin-inhibitor-alg-1007-for-dry-eye-disease/2476583/Allegro Ophthalmics announced positive results of an ex-US proof-of-concept clinical trial of the new investigational ALG-1007 topical drop drug candidate in patients with dry eye disease (DED). The results were presented by Eric D. Donnenfeld, MD, last week at the 2019 American Society of Catara
- PECAA Launches the Integrated Eye Care Initiativehttps://modernod.com/news/pecaa-launches-the-integrated-eye-care-initiative/2476579/PECAA, a nationwide doctor alliance group for independent eye care professionals, has launched a new program, the “Integrated Eye Care Initiative,” which is aimed at driving informed decision making for th
- Clinical Study Showing Reduced Incidence of Cystoid Macular Edema with Omidria Presented at ASCRShttps://modernod.com/news/clinical-study-showing-reduced-incidence-of-cystoid-macular-edema-with-omidria-presented-at-ascrs/2476575/Omeros announced the results of a real-world clinical study showing that its FDA-approved ophthalmic drug Omidria (phenylephrine and ketorolac intraocular solution) 1% / 0.3% decreases the incidence of postoperative cystoid macular edema (CME), a sight-threatening complication of cataract surgery
- Drusen Characteristics Linked With AMD Risk in Fellow Eyeshttps://modernod.com/news/drusen-characteristics-linked-with-amd-risk-in-fellow-eyes/2476571/In patients with unilateral neovascular age-related macular degeneration (AMD), certain drusen features are associated with conversion to neovascular AMD in the fellow eye, according to a secondary analysis of data from a clinical trial, as re
- Noveome Biotherapeutics Announces Publication of Further Preclinical Results Supporting the Neuroprotective Properties of ST266 in Retinal Ganglion Cellshttps://modernod.com/news/noveome-biotherapeutics-announces-publication-of-further-preclinical-results-supporting-the-neuroprotective-properties-of-st266-in-retinal-ganglion-cells/2476572/Noveome Biotherapeutics announced the publication of preclinical results for ST266, its proprietary, cell-free platform biologic, published in the Journal of Neuro-Ophthalmology. These new results further support the neuroprotective properties of intranasally delivered ST266 in mice with e
- Cholesterol-Lowering Drugs Tied to Reduced Glaucoma Riskhttps://modernod.com/news/cholesterol-lowering-drugs-tied-to-reduced-glaucoma-risk/2476570/High cholesterol is associated with an increased risk of developing glaucoma, but a new study suggests taking statins to lower cholesterol helps to reduce this risk, according to a Reuters